Literature DB >> 19235917

Bifidobacterium animalis causes extensive duodenitis and mild colonic inflammation in monoassociated interleukin-10-deficient mice.

James P Moran1, Jens Walter, Gerald W Tannock, Susan L Tonkonogy, R Balfour Sartor.   

Abstract

BACKGROUND: We recently showed that Bifidobacterium animalis is more prevalent within the colons of interleukin (IL)-10-deficient (-/-) mice than in wildtype (WT) animals colonized with the same specific pathogen-free (SPF) fecal contents. Here we tested the ability of this organism to cause T-cell-mediated intestinal inflammation by introducing it into germ-free (GF) IL-10-/- mice.
METHODS: GF IL-10-/- or WT mice were monoassociated with Bifidobacterium animalis subsp. animalis ATCC (American Type Culture Collection, Manassas, VA) 25527(T) or with B. infantis ATCC 15697(T). Inflammation was measured by blinded histologic scores of the duodenum, cecum, and colon and by spontaneous secretion of IL-12/IL-23 p40 from colonic explants. Bacterial antigen-specific CD4(+) mesenteric lymph node (MLN) T-cell recall responses were measured in response to antigen-presenting cells (APC) pulsed with bacterial lysates.
RESULTS: B. animalis caused marked duodenal inflammation and mild colitis in monoassociated IL-10-/- mice, whereas the intestinal tracts of WT animals remained free of inflammation. B. infantis colonization resulted in mild inflammation in the duodena of IL-10-/- mice. CD4(+) MLN T cells from B. animalis monoassociated IL-10-/- mice secreted high levels of IFN-gamma and IL-17 in response to B. animalis lysate. B. animalis equally colonized the different intestinal regions of WT and IL-10-/- mice.
CONCLUSIONS: B. animalis, a traditional probiotic species that is expanded in experimental colitis in this model, induces marked duodenal and mild colonic inflammation and TH1/TH17 immune responses when introduced alone into GF IL-10-/- mice. This suggests a potential pathogenic role for this commensal bacterial species in a susceptible host.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19235917      PMCID: PMC2764742          DOI: 10.1002/ibd.20900

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  40 in total

1.  A colony immunoblotting method for quantitative detection of a Bifidobacterium animalis probiotic strain in human faeces.

Authors:  H Duez; C Pelletier; S Cools; E Aissi; C Cayuela; F Gavini; S Bouquelet; C Neut; J Mengaud
Journal:  J Appl Microbiol       Date:  2000-06       Impact factor: 3.772

Review 2.  Microbial influences in inflammatory bowel diseases.

Authors:  R Balfour Sartor
Journal:  Gastroenterology       Date:  2008-02       Impact factor: 22.682

Review 3.  Probiotics and safety.

Authors:  N Ishibashi; S Yamazaki
Journal:  Am J Clin Nutr       Date:  2001-02       Impact factor: 7.045

4.  Emergence of perianal fistulizing disease in the SAMP1/YitFc mouse, a spontaneous model of chronic ileitis.

Authors:  Jesús Rivera-Nieves; Giorgos Bamias; Alda Vidrich; Marco Marini; Theresa T Pizarro; Marcia J McDuffie; Christopher A Moskaluk; Steven M Cohn; Fabio Cominelli
Journal:  Gastroenterology       Date:  2003-04       Impact factor: 22.682

5.  Helicobacter hepaticus does not induce or potentiate colitis in interleukin-10-deficient mice.

Authors:  L A Dieleman; A Arends; S L Tonkonogy; M S Goerres; D W Craft; W Grenther; R K Sellon; E Balish; R B Sartor
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

6.  Genetic heterogeneity and functional properties of intestinal bifidobacteria.

Authors:  J Mättö; E Malinen; M-L Suihko; M Alander; A Palva; M Saarela
Journal:  J Appl Microbiol       Date:  2004       Impact factor: 3.772

7.  Polyphasic taxonomic analysis of Bifidobacterium animalis and Bifidobacterium lactis reveals relatedness at the subspecies level: reclassification of Bifidobacterium animalis as Bifidobacterium animalis subsp. animalis subsp. nov. and Bifidobacterium lactis as Bifidobacterium animalis subsp. lactis subsp. nov.

Authors:  Liesbeth Masco; Marco Ventura; Ralf Zink; Geert Huys; Jean Swings
Journal:  Int J Syst Evol Microbiol       Date:  2004-07       Impact factor: 2.747

8.  Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice.

Authors:  Edward Balish; Thomas Warner
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

9.  Short fractions of oligofructose are preferentially metabolized by Bifidobacterium animalis DN-173 010.

Authors:  Roel Van der Meulen; Lazlo Avonts; Luc De Vuyst
Journal:  Appl Environ Microbiol       Date:  2004-04       Impact factor: 4.792

Review 10.  Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics.

Authors:  R Balfour Sartor
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

View more
  20 in total

Review 1.  Influence of dietary components on regulatory T cells.

Authors:  Shohreh Issazadeh-Navikas; Roman Teimer; Robert Bockermann
Journal:  Mol Med       Date:  2012-02-10       Impact factor: 6.354

Review 2.  Gut microbiota and probiotics in colon tumorigenesis.

Authors:  Yuanmin Zhu; T Michelle Luo; Christian Jobin; Howard A Young
Journal:  Cancer Lett       Date:  2011-06-24       Impact factor: 8.679

Review 3.  Towards a more comprehensive concept for prebiotics.

Authors:  Laure B Bindels; Nathalie M Delzenne; Patrice D Cani; Jens Walter
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-31       Impact factor: 46.802

Review 4.  Interleukin 10 receptor signaling: master regulator of intestinal mucosal homeostasis in mice and humans.

Authors:  Dror S Shouval; Jodie Ouahed; Amlan Biswas; Jeremy A Goettel; Bruce H Horwitz; Christoph Klein; Aleixo M Muise; Scott B Snapper
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

Review 5.  Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease?

Authors:  Roberto Bringiotti; Enzo Ierardi; Rosa Lovero; Giuseppe Losurdo; Alfredo Di Leo; Mariabeatrice Principi
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

6.  Inflammatory Th1 and Th17 in the Intestine Are Each Driven by Functionally Specialized Dendritic Cells with Distinct Requirements for MyD88.

Authors:  Jie Liang; Hsin-I Huang; Fernanda P Benzatti; Amelia B Karlsson; Junyi J Zhang; Nourhan Youssef; Averil Ma; Laura P Hale; Gianna E Hammer
Journal:  Cell Rep       Date:  2016-10-25       Impact factor: 9.423

7.  Altered transcription of murine genes induced in the small bowel by administration of probiotic strain Lactobacillus rhamnosus HN001.

Authors:  Gerald W Tannock; Corinda Taylor; Blair Lawley; Diane Loach; Maree Gould; Amy C Dunn; Alexander D McLellan; Michael A Black; Les McNoe; James Dekker; Pramod Gopal; Michael A Collett
Journal:  Appl Environ Microbiol       Date:  2014-02-28       Impact factor: 4.792

Review 8.  Diet, gut microbes, and genetics in immune function: can we leverage our current knowledge to achieve better outcomes in inflammatory bowel diseases?

Authors:  Vanessa A Leone; Candace M Cham; Eugene B Chang
Journal:  Curr Opin Immunol       Date:  2014-09-15       Impact factor: 7.486

9.  Increased proportions of Bifidobacterium and the Lactobacillus group and loss of butyrate-producing bacteria in inflammatory bowel disease.

Authors:  Wei Wang; Liping Chen; Rui Zhou; Xiaobing Wang; Lu Song; Sha Huang; Ge Wang; Bing Xia
Journal:  J Clin Microbiol       Date:  2013-11-13       Impact factor: 5.948

10.  Murine Adherent and Invasive E. coli Induces Chronic Inflammation and Immune Responses in the Small and Large Intestines of Monoassociated IL-10-/- Mice Independent of Long Polar Fimbriae Adhesin A.

Authors:  Julia M Schmitz; Susan L Tonkonogy; Belgin Dogan; Anna Leblond; Kristi J Whitehead; Sandra C Kim; Kenneth W Simpson; R Balfour Sartor
Journal:  Inflamm Bowel Dis       Date:  2019-04-11       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.